Revolution Medicines, Inc. is 11.9x more valuable than Relay Therapeutics, Inc. by market capitalization ($30.74 B vs $2.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RLAY | RVMD |
|---|---|---|
| Market cap | $2.58 B | $30.74 B |
| US-listed rank | #1916 | #453 |
| Revenue (latest FY) | $15.36M | $0.00 |
| Net income (latest FY) | -$276.48M | -$1.13B |
| Net margin | -1800.6% | - |
| SEC filings | 506 | 782 |
Revolution Medicines, Inc. is 11.9x more valuable than Relay Therapeutics, Inc. by market capitalization ($30.74 B vs $2.58 B).
In their latest fiscal years, Relay Therapeutics, Inc. reported $15.36M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Relay Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.